The iShares ESG Aware MSCI USA Small-Cap ETF (ESML) has an implied analyst target price of $48.01 per unit, indicating a potential upside of 19.98% from its current trading price of $40.02 as of the latest data. This projection is based on the 12-month forward target prices of its underlying holdings.
Three significant holdings contributing to this outlook include MoonLake Immunotherapeutics (MLTX), which is currently priced at $43.00 with an average analyst target of $77.00 (79.07% upside); RxSight Inc (RXST) trading at $13.50 with a target of $21.18 (56.90% upside); and Ribbon Communications Inc (RBBN) at $3.89 with a target of $5.90 (51.67% upside).
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| iShares ESG Aware MSCI USA Small-Cap ETF | ESML | $40.02 | $48.01 | 19.98% |
| MoonLake Immunotherapeutics | MLTX | $43.00 | $77.00 | 79.07% |
| RxSight Inc | RXST | $13.50 | $21.18 | 56.90% |
| Ribbon Communications Inc | RBBN | $3.89 | $5.90 | 51.67% |
